Cover Image

Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors: guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

Infectious complications are a significant cause of morbidity and mortality in patients with malignancies specifically when receiving anticancer treatments. Prevention of infection through vaccines is an important aspect of clinical care of cancer patients. Immunocompromising effects of the underlyi...

Full description

Saved in:
Bibliographic Details
Main Authors: Rieger, Christina (Author) , Buchheidt, Dieter (Author) , Egerer, Gerlinde (Author) , Giesen, Nicola (Author)
Corporate Author: Deutsche Gesellschaft für Hämatologie und Onkologie, Arbeitsgemeinschaft Infektiologie (Author)
Format: Article (Journal)
Language:English
Published: 24 April 2018
In: Annals of oncology
Year: 2018, Volume: 29, Issue: 6, Pages: 1354-1365
ISSN:1569-8041
DOI:10.1093/annonc/mdy117
Online Access:Verlag, Volltext: https://doi.org/10.1093/annonc/mdy117
Verlag: http://www.sciencedirect.com/science/article/pii/S0923753419348975
Get full text
Author Notes:C. T. Rieger, B. Liss, S. Mellinghoff, D. Buchheidt, O. A. Cornely, G. Egerer, W. J. Heinz, M. Hentrich, G. Maschmeyer, K. Mayer, M. Sandherr, G. Silling, A. Ullmann, M. J. G. T. Vehreschild, M. von Lilienfeld-Toal, H. H. Wolf, N. Lehners
Description
Summary:Infectious complications are a significant cause of morbidity and mortality in patients with malignancies specifically when receiving anticancer treatments. Prevention of infection through vaccines is an important aspect of clinical care of cancer patients. Immunocompromising effects of the underlying disease as well as of antineoplastic therapies need to be considered when devising vaccination strategies. This guideline provides clinical recommendations on vaccine use in cancer patients including autologous stem cell transplant recipients, while allogeneic stem cell transplantation is subject of a separate guideline. The document was prepared by the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) by reviewing currently available data and applying evidence-based medicine criteria.
Item Description:Gesehen am 14.02.2020
Physical Description:Online Resource
ISSN:1569-8041
DOI:10.1093/annonc/mdy117

Similar Items